IRIS - Res&Arch Institutional Research Information System - Research & Archive

NENCI, Giuseppe Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.699
EU - Europa 1.469
AS - Asia 902
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 4.073
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.686
HK - Hong Kong 664
UA - Ucraina 480
IE - Irlanda 319
SE - Svezia 152
IT - Italia 115
FI - Finlandia 92
DE - Germania 90
VN - Vietnam 89
RU - Federazione Russa 77
TR - Turchia 68
CN - Cina 58
GB - Regno Unito 50
FR - Francia 36
CA - Canada 13
CH - Svizzera 13
BE - Belgio 12
PL - Polonia 9
NL - Olanda 8
SG - Singapore 7
UZ - Uzbekistan 6
AT - Austria 4
CZ - Repubblica Ceca 4
GR - Grecia 4
LB - Libano 4
BG - Bulgaria 3
EU - Europa 2
AM - Armenia 1
ID - Indonesia 1
IN - India 1
IR - Iran 1
JP - Giappone 1
MY - Malesia 1
NO - Norvegia 1
ZA - Sudafrica 1
Totale 4.073
Salva come PNG Salva come JPEG
Città #
Hong Kong 664
Chandler 342
Dublin 319
Jacksonville 268
San Mateo 197
Dong Ket 88
Medford 82
Princeton 82
Ann Arbor 79
Altamura 70
Izmir 68
Wilmington 64
Andover 48
Des Moines 48
Lawrence 41
Beijing 33
Saint Petersburg 23
Ashburn 18
Shanghai 16
Los Angeles 13
Perugia 13
Brussels 12
Norwalk 12
Ottawa 12
Woodbridge 12
Helsinki 10
New York 10
Moscow 8
Boardman 7
Den Haag 7
Auburn Hills 6
San Paolo di Civitate 6
Houston 5
Dearborn 4
Kraków 4
Philadelphia 3
Singapore 3
Sofia 3
Capua 2
Casalbordino 2
Ciampino 2
London 2
Marsciano 2
Prague 2
Tappahannock 2
Biandronno 1
Cedar Rapids 1
Chicago 1
Dallas 1
Edinburgh 1
Fano 1
Foligno 1
Hanoi 1
Hebei 1
Hyderabad 1
Imperial Beach 1
Johannesburg 1
Kiev 1
Kish 1
Kuala Lumpur 1
Langley 1
Lausanne 1
Leawood 1
Mountain View 1
New Castle 1
Oslo 1
Palermo 1
Paterson 1
Pekanbaru 1
Redwood City 1
Rome 1
San Francisco 1
Santa Maria 1
Sassari 1
Vienna 1
Yerevan 1
Totale 2.745
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 505
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 118
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 104
A case of Capnocytophaga canimorsus sepsis and suspected myocardial injury following a dog bite 90
Risk factor for upper limb deep vein thrombosis 71
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 70
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 69
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 67
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 67
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 65
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 65
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 64
Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats 61
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 61
Intracellular signal transduction mechanisms regulating the release of lysosomes by activated human platelets 61
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 60
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 59
Kidney failure and endothelial disfunction: effects of haemodialysis 56
Profilassi della trombosi venosa profonda in neurochirurgia 54
Effect of different plasma expanders on erythrocyte filterability 54
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 54
Effect of glyceryl trinitrate on distensibility of peripheral muscular arteries in humans is not mediated by prostaglandins 49
Evaluation of the antithrombotic activity of unfractioned heparin or nadroparine after oral administration in man 48
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 48
Differences between human platelets erythrocyte membranes.A spectroscopic study with particular refernce to IR and Laser Raman spectroscopy. 47
Effect of pentoxifylline on platelet aggregation 47
Choline plasmalogen biosynthesis by transmethylation in human platelets 47
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. 46
Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial 46
Characterization of N, N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets. 46
Generation of arachidonic acid metabolites from stimulated whole blood in patients with chronic myeloproliferative disorders 46
Platelet activation and allergic asthma. 46
Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism 45
Clotting activation after blood transfusion in patients receiving 5-fluorouracil and mitomycin -C treatment 45
Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report 44
Diagnostica generale delle malattie emorragiche. 44
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system 43
Erythocyte deformability changes in normal pregnancy and preeclampsia 43
Vincristine-loaded platelets for autoimmune thrombocytopenic purpura 43
Interaction beteween thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anticoagulant treatment 42
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 42
Ultraviolet spectra of membrane-rich human platelet particulates. Normal data and specular abnormalities in hypo- and hyper-betalipoproteinemia 42
High shear stress induces nitric oxide synthesis in human platelets - 41
Risk factor for upper extremity deep vein thrombosis 41
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement 41
Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression 41
A randomized study on eversion versus standard carotid endarterectomy: Study design and preliminary results: The EVEREST Trial 41
Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial 41
Cholinephosphotransferase activity in human platelet 41
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 39
Treatment of intermittent claudication with mesoglycan - a placebo-controlled, double - blind study. 39
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 39
Liquid Nitrogen Snap Frozen Saphenous Vein for Vascular Access in Dialysis 39
Evidence for platelet activation in allergic asthma. 39
Red cell deformability alterations in normal late pregnancy: possible role of plasma components 38
Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets. Role of adenylylcyclase up-regulation 37
Human blood platelets release their lysosomal content ''in vivo'' at a localized site of platelet activation 37
Erythrocyte deformability in pre-eclamptic women and their newborn in the evaluation of microcirculatory impairment. 37
Inhibition of fluid phase and fibrin bound thrombin: effect of heparin, r-hirudin, PEG-rm-hirudin and a thrombin exosite inhibitor 36
Thrombolytic therapy for thromboembolism of vertebrobasilar artery. 36
Heparin and local haemostasis 35
In vitro and ex vivo effect of indobufen on red blood cell deformability. 34
The reduced erythrocyte deformability in pre-eclampsia is due to altered plasma to red blood cell interactions 34
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. 33
Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. 33
Thrombolytic therapy for thromboembolism of the vertebrobasilar artery. 33
Intrinsically defective or exhausted platelets in hairy cell leukemia? 32
Infusion of vincristine-loaded platelets in acute ITP refractory to steroids: an alternative to splenectomy 32
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 32
Platelets release their lysosomal content in vivo in humans upon activation 31
Platelets and asthma 31
La safena omologa crioconservata come accesso dialitico: valutazione biologica e clinica 31
Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic diseases. 30
New pyridazinone derivatives as inhibitors of platelet aggregation. 30
Platelets release lambda-granules (lysosomes) in vivo in humans upon activation 30
Ruolo del sistema emostatico nella patologia cardiovascolare. Generalità. 30
Vinca-loaded platelets 28
Platelet glycohydrolase activities: characterization and release 27
Treatment of intermittent claudication with medoglycan- a placebo-controlled, double-blind study 27
Interactions between platelets, other cells and eicosanoids in hypertension. 26
Thromboxane does not play a significant role in acute, cold induced vasoconstriction in raynaud’s phenomenon 26
Intraoperative assessment of technical perfection in carotid endarterectomy: a prospective analysis of 1305 completion procedures 26
Totale 4.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.895
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201977 0 0 0 0 0 0 0 0 0 0 76 1
2019/2020399 11 4 70 3 68 9 71 17 75 32 7 32
2020/2021782 2 76 20 71 229 26 75 1 90 16 79 97
2021/2022631 9 115 18 27 20 2 6 230 4 16 70 114
2022/20231.135 94 191 26 84 83 140 0 51 409 1 34 22
2023/2024827 30 43 22 4 6 2 645 12 33 17 13 0
Totale 4.198